Skip to main content
SpringerLink
Log in

Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Little is known regarding the effectors of lymphokine-activated killer activity. Lysosomotropic agents such as quinacrine can be used to positively sort for lysosome rich cells in natural killer (NK) cell populations. We therefore decided to use this agent to sort lymphokine-activated killer (LAK) cells to characterize their lysosomal content. We found that the positively sorted population contained all the LAK activity, i.e., lysis of NK-resistant tumor cells (B16 melanoma cell line), with the negatively sorted cells having no killing activity. Therefore separation of interleukin-2-incubated cells for LAK activity could be accomplished using sorting after quinacrine staining. The treatment of positively sorted LAK cell populations with L-leucine methyl ester, a lysosomotropic dye which inhibits killing by lysosome rich cells, caused abrogation of killing of the B16 tumor by the treated populations. Single cell conjugate assays were also done on these sorted cells, with positively sorted cells forming the highest and negatively sorted cells the lowest percent of conjugates. Our data therefore indicates the important role of lysosome rich cells in the LAK cell population in the murine system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allison AC, Young MR (1964) Uptake of dyes and drugs by living cells in culture. Life Sci 3:1407

    Google Scholar 

  2. Bradley TP, Bonavida B (1982) Mechanism of cell mediated cytotoxicity at the single cell level. IV. Natural killing and antibody dependent cellular cytotoxicity can be mediated by the same human effector cells as determined by two target conjugate assay. J Immunol 129:2260

    Google Scholar 

  3. Ettinghausen SE, Lipford III EH, Mule JJ, Rosenberg SA (1985) Recombinant interleukin-2 stimulates in vivo proliferation of adoptively transferred lymphokine activated killer (LAK) cells. J Immunol 135:3623

    Google Scholar 

  4. Goldman R, Kaplan A (1973) Rupture of rat liver lysosomes mediated by L-amino acid esters. Biochim Biophys Acta 318:205

    Google Scholar 

  5. Grimm EA, Rosenberg SA (1984) In: Pick E (ed) Lymphokines vol 9. Academic Press, Orlando, FL, p 279

    Google Scholar 

  6. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823

    Article  CAS  PubMed  Google Scholar 

  7. Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JYU, Rosenberg SA (1983) Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus derived lymphocytes, and natural killer cells. J Exp Med 157:884

    Google Scholar 

  8. Kasahara T, Dejeu JY, Dougherty SF, Openheim JJ (1983) Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: Interleukin 2, interferon, and colony stimulating factor. J Immunol 131:2379

    Google Scholar 

  9. Lafreniere R, Rosenberg SA (1985) Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin-2 (RIL-2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and adenocarcinoma. J Immunol 135:4273

    Google Scholar 

  10. Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T cell growth factor. Cancer Res 41:4420

    Google Scholar 

  11. Mazumder A, Rosenberg SA (1984) Successful immunotherapy of NK-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin-2. J Exp Med 159:495

    Google Scholar 

  12. Mazumder A, Grimm EA, Rosenberg SA (1983) Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization. Cancer Immunol Immunother 15:1

    Google Scholar 

  13. Mazumder A, Rosenstein M, Rosenberg SA (1983) Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes. Cancer Res 43:5729

    Google Scholar 

  14. Merluzzi VJ, Savage DM, Mertelsmann R, Welte K (1984) Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin-2. Cell Immunol 84:74

    Google Scholar 

  15. Mule JJ, Ettinghauser SE, Spiess DJ, Shu S, Rosenberg SA (1986) Antitumor efficacy of lymphokine activated killer cell and recombinant interleukin-2 in vivo survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. Cancer Res 46:676

    Google Scholar 

  16. Neighbour PS, Huberman HS (1982) Sr2+ induced inhibition of human natural killer (NK) cell-mediated cytotoxicity. J Immunol 128:2236

    Google Scholar 

  17. Ohkuma S, Poole B (1981) Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substance. J Cell Biol 90:656

    Google Scholar 

  18. Reeves JP (1979) Accumulation of amino acids by lysosomes incubated with amino acid methyl esters. J Biol Chem 254:8914

    Google Scholar 

  19. Reeves JP, Decker RS, Crie S, Wildenthal K (1981) Intracellular disruption of rat heart lysosomes by leucine methyl ester: Effects on protein degradation. Proc Natl Acad Sci USA 78:4426

    Google Scholar 

  20. Rosenberg S (1985) Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. J Natl Cancer Inst 75 (4):594

    Google Scholar 

  21. Rosenberg SA, Lotze MT, Mull LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systematic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New Engl J Med 313:1485

    Google Scholar 

  22. Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA (1984) Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin-2. Cancer Res 44:1946

    Google Scholar 

  23. Shau H, Golub SH (1981) Depletion of NK cells with lysomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells. J Immunol 134:1136

    Google Scholar 

  24. Shau H, Dawson JR (1984) The role of the lysosome in natural killing: Inhibition by lysosomotropic vital dyes. Immunology 53:745

    Google Scholar 

  25. Shau H, Dawson JR (1985) Identification and purification of NK cells with lysosomotropic vital stains: Correlation of lysosome content with NK activity. J Immunol 135:137

    Google Scholar 

  26. Shau H, Dawson JR (1985) Regulation of human natural killing by lysosomotropic and thiol-reactive agents. Immunology 55:647

    Google Scholar 

  27. Thiele DL, Lipsky PE (1985) Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononu-clear cells. J Immunol 134:786

    Google Scholar 

  28. Thiele DL, Mokurasaka, Lipsky PE (1983) Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. J Immunol 131:2282

    Google Scholar 

  29. Timonen T, Saksela E, Virtanen I, Cantell K (1980) Natural killer cells are responsible for the interferon production induced in human lymphocytes by tumor cells. Eur J Immunol 10:423

    Google Scholar 

  30. Verhof J, Sharman SD (1983) Inhibition of human natural killer activity by lysomotropic agents. J Immunol 131:125

    Google Scholar 

  31. Whittekind D, Starbesand J (1970) On dye dependent variation of cellular pathology. I. Communication: Neutral red and Mepacrine Cytobiologie 2:275

  32. Yron I, Wood TA, Spiess PJ, Rosenberg SA (1980) In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. J Immunol 125:238

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Southern California School of Medicine and Norris Cancer Hospital and Research Institute, 90033, Los Angeles, CA, USA

    Ravin Agah, Hungyi Shau & Amitabha Mazumder

Authors
  1. Ravin Agah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hungyi Shau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amitabha Mazumder
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by NIH grants R01 CA42962 and K04 CA0122, and by intramural funds from the Norris Cancer Center

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agah, R., Shau, H. & Mazumder, A. Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations. Cancer Immunol Immunother 24, 247–252 (1987). https://doi.org/10.1007/BF00205638

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205638

Keywords

Search

Navigation